Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michelle Ehrlich

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Molecular Neurodegeneration|March 9, 2010
Extensive proteomic screening identifies the obesity-related NYGGF4 protein as a novel LRP1-interactor, showing reduced expression in early Alzheimer's diseaseYuji Kajiwara, Sonia Franciosi, Nagahide Takahashi, et al.
Molecular Cell|April 15, 2021
The dystonia gene THAP1 controls DNA double-strand break repair choiceKenta Shinoda, Dali Zong, Elsa Callen, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|May 25, 2016
Effective anti-Alzheimer Aβ therapy involves depletion of specific Aβ oligomer subtypesElysse M Knight, Soong Ho Kim, Jessica C Kottwitz, et al.
Genome Medicine|November 2, 2016
Integrative network analysis of nineteen brain regions identifies molecular signatures and networks underlying selective regional vulnerability to Alzheimer's diseaseMinghui Wang, Panos Roussos, Andrew McKenzie, et al.
Scientific Data|September 12, 2018
The Mount Sinai cohort of large-scale genomic, transcriptomic and proteomic data in Alzheimer's diseaseMinghui Wang, Noam D Beckmann, Panos Roussos, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Molecular Neurodegeneration|March 9, 2010
Extensive proteomic screening identifies the obesity-related NYGGF4 protein as a novel LRP1-interactor, showing reduced expression in early Alzheimer's diseaseYuji Kajiwara, Sonia Franciosi, Nagahide Takahashi, et al.
Molecular Cell|April 15, 2021
The dystonia gene THAP1 controls DNA double-strand break repair choiceKenta Shinoda, Dali Zong, Elsa Callen, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|May 25, 2016
Effective anti-Alzheimer Aβ therapy involves depletion of specific Aβ oligomer subtypesElysse M Knight, Soong Ho Kim, Jessica C Kottwitz, et al.
Genome Medicine|November 2, 2016
Integrative network analysis of nineteen brain regions identifies molecular signatures and networks underlying selective regional vulnerability to Alzheimer's diseaseMinghui Wang, Panos Roussos, Andrew McKenzie, et al.
Scientific Data|September 12, 2018
The Mount Sinai cohort of large-scale genomic, transcriptomic and proteomic data in Alzheimer's diseaseMinghui Wang, Noam D Beckmann, Panos Roussos, et al.
Pageof 2